駱志國(guó)主任醫(yī)師

駱志國(guó)，男，漢族，1973年6月生，教授、主任醫(yī)師、中共黨員，博士研究生學(xué)歷，碩士研究生導(dǎo)師。現(xiàn)任十堰市太和醫(yī)院（湖北醫(yī)藥學(xué)院附屬太和醫(yī)院）腫瘤防治中心主任，腫瘤防治中心黨支部書(shū)記。湖北省抗癌協(xié)會(huì)常務(wù)理事、湖北省抗癌協(xié)會(huì)肺癌專(zhuān)業(yè)委員會(huì)副主任委員、湖北省抗癌協(xié)會(huì)淋巴瘤專(zhuān)業(yè)委員會(huì)副主任委員、湖北省抗癌協(xié)會(huì)青年委員會(huì)副主任委員、十堰市抗癌協(xié)會(huì)理事長(zhǎng)。湖北省“五四”青年獎(jiǎng)?wù)芦@得者、湖北醫(yī)藥學(xué)院教學(xué)園丁獎(jiǎng)獲得者。 主要從事腫瘤的早期診斷、治療、研究與教學(xué)工作，主要研究方向?yàn)橐苑暖煘橹行牡哪[瘤綜合治療、腫瘤放射抗拒和化療耐藥的分子機(jī)制，主持國(guó)家自然科學(xué)基金青年基金項(xiàng)目、湖北省衛(wèi)生廳重點(diǎn)項(xiàng)目、湖北省教育廳青年人才項(xiàng)目等重大項(xiàng)目的課題研究。2011年，參與研究《褪黑素抗腫瘤血管生成作用》，獲得十堰市科技進(jìn)步一等獎(jiǎng)（排名第三）。2015年，主持《胃癌侵襲與轉(zhuǎn)移的機(jī)制及防治》研究，獲得十堰市科技進(jìn)步二等獎(jiǎng)（排名第一）。2016年，主持《胃癌侵襲與轉(zhuǎn)移的機(jī)制及防治》研究，獲得湖北省科技進(jìn)步三等獎(jiǎng)（排名第一）。目前已在國(guó)內(nèi)外期刊發(fā)表論文22篇，其中SCI論文14篇。Professor Zhiguo Luo, Ph.D., Branch Director, Department of Oncology, Taihe Hospital, Shiyan, Hubei, China. Comprehensive Treatment of Tumor and Mechanisms on Radio-/Chemo-therapy Resistance. EDUCATIOND. Sc. and M. Sc. (Radiation Oncology): Wuhan University, 2001-2006.B. Sc. (Clinical Medicine): Hubei University of Medicine, 1993-1998.WORKING EXPERIENCE2016-, Professor, First Clinical College, Hubei University of Medicine; Branch Director, Department of Oncology, Taihe Hospital.2006-2016, Associate Professor, First Clinical College, Hubei University of Medicine; Branch Director, Department of Oncology, Taihe Hospital.1998-2001, Assistant, First Clinical College, Hubei University of Medicine; Attending Doctor, Department of Oncology, Taihe Hospital.AWARDS AND HONORSFirst Prize of Shiyan Science and Technology Progress Award (2012)Second Prize of Shiyan Science and Technology Progress Award (2015)Third Prize of Hubei Science and Technology Progress Award (2016)Hubei Province “May 4th” Youth Medal Hubei University of Medicine Teaching gardener AwardACADEMIC SERVICEExecutive Director, Hubei Anti-cancer AssociationVice Deputy Director, Committee of Lung Cancer, Hubei Anti-cancer AssociationVice Deputy Director, Committee of Malignant lymphoma, Hubei Anti-cancer AssociationSELECTED PUBLICATIONS1. Zhong YH, Liao ZK, Zhou FX, Xie CH, Xiao CY, Pan DF, Luo ZG, Liu SQ, Zhou YF. Relationship between telomere length and radiosensitivity in varous human cancer cell lines. Biochem Biophys Res Commun. 2008,367(1)

腫瘤的精確放療、生物靶向治療